The stock of Hims & Hers Health Inc. (HIMS) fell more than 4% in after-hours trading after the telehealth company issued ...

Yachiyo Kuge of Tokyo, Japan, who lost her son Toshiya in the Sept. 11, 2001 attacks, attends during the Flight 93 National ...

At Sitara Textile Mills in Faisalabad, once a beacon of industrial pride and among Pakistan’s largest textile manufacturers, a haunting silence now hovers where once the rhythmic hum of looms ...

The first 100 days of Donald J. Trump’s second presidency have been a study of extremes, especially when compared with the start of presidential terms over the last century. Compared with other ...

After taking legal action against the companies making and distributing compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were ...

Telehealth, also called telemedicine, aims to make healthcare more accessible and a lot more convenient. No taking time off work, waiting weeks for an appointment, or circling the block to find ...

Telemedicine is a safe and convenient way to seek mental health services in an increasingly virtual world. If you’re considering seeing a psychiatrist but prefer to hold sessions remotely ...

Optional sortable table view, after selecting this view, select a climate index and data period. The table is displayed before the graph. Selected data is loading, please wait. An index is a measure ...

An index is a measure (often a numerical value) that can be representative of a particular pattern or state of a system. Climatologists monitor several indices, some ocean-based and some atmospheric, ...

Hims & Hers Health Inc. soared after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy comes as ...

Novo Nordisk on Tuesday said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health, Ro and LifeMD to expand access to the blockbuster treatment now that it is ...

Shares of Hims & Hers closed up 23% on Tuesday, while Novo Nordisk's stock closed up 4%. The Danish drugmaker is racing to capture more patients now that many compounding pharmacies are legally ...